Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan) Jun 02, 2008 Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan) May 30, 2008 Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit May 22, 2008 Amikacin Inhale Shows Promising Results in Phase II Study May 19, 2008 Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings May 16, 2008 Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress May 12, 2008 NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting May 07, 2008 Nektar Receives Patent Covering Pulmonary Targeted Antibiotics May 07, 2008 Nektar Therapeutics Announces First Quarter 2008 Results May 07, 2008 Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets Apr 30, 2008 Pagination First page « first Previous page ‹ previous … Page 41 Page 42 Page 43 Page 44 Current page 45 Page 46 Page 47 Page 48 Page 49 … Next page next › Last page last »